Advertisement

Topics

"Consultant suspended nine months risking patient safety" Drugs and Medication Database

19:09 EST 22nd November 2017 | BioPortfolio

Here are the most relevant "Consultant suspended nine months risking patient safety" Drugs and Medications that we have found in our database.

More Information about "Consultant suspended nine months risking patient safety" on BioPortfolio

We have published hundreds of Consultant suspended nine months risking patient safety news stories on BioPortfolio along with dozens of Consultant suspended nine months risking patient safety Clinical Trials and PubMed Articles about Consultant suspended nine months risking patient safety for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Consultant suspended nine months risking patient safety Companies in our database. You can also find out about relevant Consultant suspended nine months risking patient safety Drugs and Medications on this site too.

Showing "Consultant suspended nine months risking patient safety" Drugs and Medications 1–25 of 37

Possibly Relevant

Hectorol [Genzyme Corporation]

Videx [Bristol-Myers Squibb Company]

These highlights do not include all the information needed to use VIDEX safely and effectively. See full prescribing information for VIDEX. VIDEX (didanosine, USP) Pediatric Powder for Oral SolutionInitial U.S. Approval: 1991

Hectorol [Genzyme Corporation]

Videx ec [Bristol-Myers Squibb Company]

These highlights do not include all the information needed to use VIDEX EC safely and effectively. See full prescribing information for VIDEX EC. VIDEX EC (didanosine, USP) Delayed-Release Capsules         Enteric-Coated Beadlets Initial U.S

Leflunomide [NorthStar RxLLC]

Leflunomide Tablets USP

Didanosine [Barr Laboratories Inc.]

These highlights do not include all the information needed to use didanosine delayed-release capsules safely and effectively. See full prescribing information for didanosine delayed-release capsules. Initial U.S. Approval: 1991

Retrovir [GlaxoSmithKline LLC]

RETROVIR (zidovudine)IV Infusion FOR INTRAVENOUS INFUSION ONLY

Didanosine [Mylan Pharmaceuticals Inc.]

These highlights do not include all the information needed to use didanosine delayed-released capsules safely and effectively. See full prescribing information for Didanosine Delayed-Release Capsules. Didanosine Delayed-Release Capsules(Enteric-Coat

Retrovir [ViiV Healthcare Company]

RETROVIR (zidovudine)IV Infusion FOR INTRAVENOUS INFUSION ONLY

Baby orajel teething medicine [Church & Dwight Co., Inc.]

DRUG FACTS

Didanosine [State of Florida DOH Central Pharmacy]

These highlights do not include all the information needed to use Didanosine Delayed-Release Capsules Enteric-Coated Pellets safely and effectively. See full prescribing information for Didanosine Delayed-Release Capsules Enteric-Coated Pellets. Initial

Zerit [E.R. Squibb & Sons, L.L.C.]

These highlights do not include all the information needed to use ZERIT safely and effectively. See full prescribing information for ZERIT. ZERIT (stavudine) CapsulesZERIT (stavudine) for Oral SolutionInitial U.S. Approval: 1994

Vivotif-b [Rebel Distributors Corp]

Vivotif-B

Ranitidine [WOCKHARDT USA LLC]

PRODUCT INFORMATION Rx Only

Ranitidine [WOCKHARDT LIMITED]

PRODUCT INFORMATION Rx Only

Ranitidine [WOCKHARDT USA LLC.]

PRESCRIBING INFORMATION Ranitidine Tablets USP, 150 mg and 300 mg

Ranitidine [WOCKHARDT LIMITED]

PRESCRIBING INFORMATION Ranitidine Tablets USP, 150 mg and 300 mg

Stavudine [Mylan Pharmaceuticals Inc.]

These highlights do not include all the information needed to use stavudine safely and effectively. See full prescribing information for stavudine capsules.  Stavudine Capsules, USP Initial U.S. Approval: 1994

Epivir [KAISER FOUNDATION HOSPITALS]

These highlights do not include all the information needed to use EPIVIR safely and effectively. See full prescribing information for EPIVIR.EPIVIR (lamivudine) Tablets and Oral SolutionInitial U.S. Approval: 1995

Stavudine [Cipla Limited]

These highlights do not include all the information needed to use Stavudine safely and effectively. See full prescribing information for Stavudine. Stavudine For Oral Solution USP 1mg/mL Initial U.S. Approval: 1994

Didanosine [American Health Packaging]

Didanosine Delayed-Release Capsules (enteric-coated pellets)

Didanosine [American Health Packaging]

Didanosine Delayed-Release Capsules (enteric-coated pellets)

Letrozole [APP Pharmaceuticals, LLC]

These highlights do not include all the information needed to use Letrozole Tablets, USP safely and effectively. See full prescribing information for Letrozole Tablets, USP Letrozole Tablets, USPInitial U.S. Approval: 1997

Simvastatin [MedVantx, Inc.]

These highlights do not include all the information needed to use simvastatin safely and effectively. See full prescribing information for simvastatin tablets. Simvastatin Tablets, USP Initial U.S. Approval: 1991

Simvastatin [MedVantx, Inc.]

These highlights do not include all the information needed to use simvastatin safely and effectively. See full prescribing information for simvastatin tablets. Simvastatin Tablets, USP Initial U.S. Approval: 1991



Quick Search
Advertisement